Aptiv Solutions, SAS Foster Innovative Approaches to Faster, Better Drug Trials

Two Companies Team to Bring Adaptive Clinical Trial Design to Life Science Companies

RESTON, Virg.--(BUSINESS WIRE)-- Two industry leaders will jointly drive advanced clinical trial design and deployment of adaptive clinical trials. An agreement between Aptiv Solutions, a leader in designing and executing adaptive clinical trials, and SAS, the leader in Business Analytics, helps life sciences organizations bring new drugs to market with increased success and faster delivery.

The two companies will work in tandem to automate workflow and improve drug trial design through simulation and efficient execution. This more dynamic and scalable approach to drug development, designed to eliminate operational barriers to performing adaptive clinical trials, can be applied both to drugs and medical devices.

“The difficulties facing companies developing products in life sciences continue to intensify,” said Jason Burke, Director, SAS Center for Health Analytics and Insights (CHAI). “Companies that rely on conventional techniques risk missing out on emerging opportunities and the successes that typically follow. Adaptive clinical trials can mean the difference between being a market leader and lagging behind.”

Aptiv Solutions and SAS are uniquely capable of driving widespread adoption of adaptive clinical trials, which require sophisticated data models and a deep understanding of the clinical trial testing process.

SAS, the “gold standard” for advanced data modeling software, offers analytic solutions for all types of users. Aptiv Solutions contributes an in-depth understanding of the pressures and challenges facing drug and medical device developers. Aptiv Solutions combines a team of leading experts in designing adaptive trials with extensive clinical, regulatory and statistical experience to implement them.

Aptiv Solutions Chairman and CEO Patrick Donnelly said: “We are sharply focused on harnessing the power of adaptive clinical trials. Aptiv Solutions has combined advanced simulation and software capabilities with the knowledge of adaptive clinical trial subject-matter experts and broad capabilities, and as a global CRO, Aptiv Solutions possesses deep process knowledge and flexibility in running global clinical trials. Pharmaceutical, biotech and medical device companies look to Aptiv Solutions to expose the pitfalls and unfulfilled promise of traditional development methods, while providing new alternatives and results.”

Aptiv Solutions offers:

  • Extensive experience in designing and executing adaptive clinical trials, with more than 100 completed adaptive trials.
  • An Innovation Center of internationally recognized experts in the design, simulation and execution, of adaptive trials.
  • Deep process expertise in the delivery of global clinical trials.
  • Experience in presenting adaptive trial designs to the various global regulatory agencies.
  • Specialized technology systems integrated to support design, simulation and execution of adaptive clinical trials.

SAS provides:

  • Scalable technology platform to address the near real-time data, regulatory rigor and secure data access needed in adaptive clinical trials.
  • Advanced analytics to continually improve the trial process.
  • Visualization technology, including mobile, to enhance decision making.

SAS in Health Analytics

SAS is the industry leader in health analytics software and services, delivering best-in-class solutions for improving medical care, strengthening financial performance, deepening customer relationships, and pursuing medical innovations. All of the top 25 health plans and pharmaceutical companies depend on SAS for strategic insights into health outcomes, profitability, and customer preferences and behaviors that produce useful intelligence for business transformation and growth.

About Aptiv Solutions

Aptiv Solutions is a global biopharmaceutical and medical device development services company focused on recognizing, understanding and enabling clients to capitalize on rapid and fundamental changes facing companies developing products in the pharmaceutical, biotech and medical device market. The company offers clients an extensive portfolio of innovative services including adaptive clinical trials, early phase product strategy, regulatory services, pharmacovigilance, clinical staffing and the operational support of a global clinical research organization. Aptiv Solutions has over 700 professionals in North America, Europe, the Middle East, Japan, and Australia, and operates out of 22 offices in 17 countries. Visit the website at www.aptivsolutions.com

About SAS

SAS is the leader in business analytics software and services, and the largest independent vendor in the business intelligence market. Through innovative solutions delivered within an integrated framework, SAS helps customers at more than 50,000 sites improve performance and deliver value by making better decisions faster. Since 1976 SAS has been giving customers around the world THE POWER TO KNOW®.

SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies. Copyright © 2011 SAS Institute Inc. All rights reserved.



CONTACT:

Aptiv Solutions
Lesley Keays, 508-597-5775
Email: [email protected]

KEYWORDS:   United States  North America  Virginia

INDUSTRY KEYWORDS:   Health  Biotechnology  Medical Devices  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.